A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care
Recruiting now
Conditions studied: Eosinophilic Esophagitis (EoE)
In brief
This observational research study is to better understand patients with eosinophilic esophagitis (EoE) who have recently been prescribed DUPIXENT® (dupilumab). The purpose of this research study is to look at how DUPIXENT is used in normal care of patients with EoE. Possible benefits to others include a better understanding of EoE and helping to inform research and clinical trial design leading to treatment decisions in this patient population going forward. Patient questionnaires will measure the following: * How EoE makes one feel * EoE signs and/or symptoms, eg, how difficult it is to swallow * How EoE affects quality-of-life * How EoE impacts aspects of daily life * How EoE symptoms have changed throughout the study
Key facts
- Study ID
- NCT06693531
- Run by
- Regeneron Pharmaceuticals
- People needed
- 350
- Starts
- 2024-11-22
- Expected to finish
- 2030-05-22
- Last updated by the study team
- 2026-06-18
Who can join
Age: 1 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Atrium Health / Wake Forest University School of Medicine — Winston-Salem, North Carolina, United States (enrolling)
- Vanderbilt University Medical Center — Nashville, Tennessee, United States (enrolling)
- Boston Childrens Hospital — Boston, Massachusetts, United States (enrolling)
- University of North Carolina at Chapel Hill — Chapel Hill, North Carolina, United States (enrolling)
- Medical University of South Carolina — Charleston, South Carolina, United States (enrolling)
- University of California, San Francisco — Oakland, California, United States (enrolling)
- Massachusetts General Hospital — Boston, Massachusetts, United States (enrolling)
- Phoenix Childrens Hospital — Phoenix, Arizona, United States (enrolling)
- Weil Cornell Medicine NYP — New York, New York, United States (enrolling)
- Gastroenterology Group of Rochester LLP — Rochester, New York, United States (enrolling)
- Arkansas Childrens Hospital — Little Rock, Arkansas, United States (enrolling)
- The Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States (enrolling)
- Yale School of Medicine — New Haven, Connecticut, United States (enrolling)
- Gastroenterology of Greater Orlando — Orange City, Florida, United States (enrolling)
- Orlando Health — Orlando, Florida, United States (enrolling)
- Stanford University — Palo Alto, California, United States (enrolling)
- GI Care for Kids LLC — Atlanta, Georgia, United States (enrolling)
- Ann & Robert H. Lurie Children's Hospital of Chicago — Chicago, Illinois, United States (enrolling)
- Childrens Hospital Colorado — Aurora, Colorado, United States (enrolling)
- Steven And Alexandra Cohen Children's Medical Center Of New York — Lake Success, New York, United States (enrolling)
- Endeavor Health, Skokie Campus — Skokie, Illinois, United States (enrolling)
- Icahn School of Medicine at Mount Sinai — New York, New York, United States (enrolling)
- Allergy & Asthma Specialists, P.S.C. — Owensboro, Kentucky, United States (enrolling)
- Boston Specialists, Chinatown Office — Boston, Massachusetts, United States (enrolling)
- Baylor College of Medicine — Houston, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.